ISSCR Guidelines for Stem Cell Research and Clinical … – PubMed
Scott SandersStem Cell ResearchNo comments

Declaration of interests R.L.-B. has no financial conflicts to declare. R.L.-B. serves on the following advisory boards: Scientific and Clinical Advances Advisory Committee of the Human Fertility and Embryo Authority; Sense About Science, Member of Board of Trustees; Public Library of Science (PLOS), Board Member, Chair of Audit Committee, Chair of Remunerations Committee, and member of Scientific Advisory Board; Royal Society, Chair of Genetic Technologies Programme, Progress Educational Trust, Chair of the Board of Trustees; member of the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing; Chair of ISSCR Task Force to Update the Guidelines; and member of External Advisory Board, Cambridge Reproduction Strategic Research Initiative, University of Cambridge, UK. R.B

Read more
Induced pluripotent stem cell-derived mesenchymal stem cells: whether …
Scott SandersStem Cell ResearchNo comments

MSCs, also referred to as mesenchymal stem cells, exhibit the potential to differentiate into a variety of mesodermal cell lineages, such as adipocytes, chondrocytes, osteocytes, and myocytes [1]. These cells are defined by the expression of specific surface markers, including CD73, CD90, and CD105, and the absence of markers such as CD45, CD34, CD14 or CD11b, CD79 or CD19, and HLA-DR [2]

Read more
Manufactured stem cells could help to treat blood cancers in the future
Scott SandersStem Cell ResearchNo comments

Monday, 07 October 2024 A cross-disciplinary team, led by the University of Glasgow, alongside the Universities of Nottingham and Strathclyde, will use pioneering technology to manufacture human stem cells outside the body, in the hope these cells could help tissue regeneration to repair broken bones, help with transplant therapies and help to develop new approaches to blood cancer treatment. The new project is made possible with 11m, awarded by the UKRI Engineering and Physical Sciences Research Council (EPSRC), as part of funding for five new research hubs aimed at tackling some of the biggest problems in healthcare and society with ground-breaking new technologies and approaches. Led by Professor Matthew Dalby from the University of Glasgows School of Molecular Biosciences, the MAINSTREAM project, which further benefits from 1.5m in partner (industry) contributions, will be a research and partnership hub for health technologies in manufacturing stem cells

Read more

Theme: Illdy.